日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

OTUD4 deubiquitination stabilizes EGFR and activates the PI3K/AKT pathway to promote the invasiveness of triple-negative breast cancer.

OTUD4 去泛素化可稳定 EGFR 并激活 PI3K/AKT 通路,从而促进三阴性乳腺癌的侵袭性。

Ren Yu, Zhou Fulin, Tan Zhihua, Yang Senguo, Zhang Shaolin, Zhang Yonglin, Fu Yumei, Zhang Mai, Liu Shu

Efficacy of Neoadjuvant Chemotherapy with Epirubicin and Cyclophosphamide and Weekly Paclitaxel and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Carcinoma: A Real-World Study

新辅助化疗联合表柔比星和环磷酰胺,每周一次紫杉醇和曲妥珠单抗治疗人表皮生长因子受体2阳性乳腺癌的疗效:一项真实世界研究

Zhang, Mengmeng; Li, Ling; Zhang, Shiyong; Zhu, Wenlong; Yang, Senguo; Di, Guangsheng; Ma, Xiaoxia; Yang, Haisong